Working together to beat
Nervous system tumours

 

Quality neuro-oncology education

 

Major UK based neuro-oncology
annual meetings

To promote high-quality neuro-oncology research, education and multi-disciplinary patient centred care

Understanding brain tumours to ensure the very best care is provided to all patients.

Find out more

Discover the latest from BNOS

Research News

Mutant IDH1 expression drives TERT promoter reactivation as part of the cellular transformation process

| Scientific/Research | No Comments

24 October 2016 Mutations in the isocitrate dehydrogenase gene IDH1 are common in lower-grade glioma where they result in the production of 2-hydroxyglutarate (2HG), disrupted patterns of histone methylation and…

Glioma and microglia, a double entendre

| Scientific/Research | No Comments

24 October 2016 Access to this article requires user login. Read more >>

PCM1 Depletion Inhibits Glioblastoma Cell Ciliogenesis and Increases Cell Death and Sensitivity to Temozolomide

| Scientific/Research | No Comments

24 October 2016 A better understanding of the molecules implicated in the growth and survival of glioblastoma (GBM) cells and their response to temozolomide (TMZ), the standard-of-care chemotherapeutic agent, is…

Dual PI3K- and mTOR-inhibitor PI-103 can either enhance or reduce the radiosensitizing effect of the Hsp90 inhibitor NVP-AUY922 in tumor cells:

| Scientific/Research | No Comments

24 October 2016 The role of drug-irradiation schedule. Inhibition of Hsp90 can increase the radiosensitivity of tumor cells. However, inhibition of Hsp90 alone induces the anti-apoptotic Hsp70 and thereby decreases…

Clinical Practice

Going beyond genetics yields clues to challenging childhood brain cancer

| Clinical | No Comments

25 November 2016 Cancer is often seen as a disease of genetic changes.  But one type of childhood brain tumour has stymied efforts to identify a recurring genetic defect. Now,…

Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas

| Clinical | No Comments

25 November 2016 This article is available to AAAS members. If you are a AAAS Member use your via AAAS ID and password to log in. Read more >>

IDH1 Mutations Might Underlie Glioma-Associated Epilepsy

| Clinical | No Comments

25 November 2016 IDH1-mutant gliomas can affect adjacent, nonmalignant cells in ways that trigger seizures, according to research reported at the 21st Annual Scientific Meeting of the Society for Neuro-Oncology,…

Diagnostic Performance and Safety of Positron Emission Tomography Using 18F-Fluciclovine in Patients with Clinically Suspected High- or Low-grade Gliomas

| Clinical | No Comments

25 November 2016 A Multicenter Phase IIb Trial The study objective was to assess the diagnostic performance of positron emission tomography (PET) for gliomas using the novel tracer 18F-fluciclovine (anti-[18F]FACBC)…